Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tobacco and Medicine: A Hazy Relationship

Simon M. Helfgott, MD  |  Issue: January 2015  |  January 1, 2015

In fact, Don Draper would be proud. By implanting the concept of throat protection in the minds of doctors and the general population, profits from sales of Philip Morris cigarettes soared, tripling within the first year of the ad campaign.2

Not to be undone, the makers of Camel cigarettes probably did more than other companies to link their product with widespread physician acceptance. Their ads promoted the concept that when it came to smoking, “experience is the best teacher.” Using a series of print ads, Camel highlighted how personal clinical experiences often helped famous doctors gain insight into critical issues. Couldn’t this concept be applied when choosing a brand of cigarettes? For example, one ad depicted how the famous German physician and scientist, Paul Ehrlich, MD, reached some important conclusions in microbiology that “helped create the science of chemotherapy, which is increasingly important today.”4 (A prescient observation for a tobacco company!) The ad went on to assert that, “experience is the best teacher in cigarettes, too,” implying that wise doctors and their patients should flock to Camel cigarettes, too.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The nascent television networks were swamped with idyllic commercials depicting the hectic lives of doctors and how puffing on Camel cigarettes provided them with well-deserved downtime.5 White men (and yes, they were only white men) in white coats, some clutching stethoscopes, others with otoscopic mirrors strapped to their foreheads, were always reaching for a Camel. These are hilarious commercials to watch and nowadays would fit perfectly as sketches on Saturday Night Live, although at the time of their release, they served more sinister roles.

A Perfect Match: Stress & Cigarettes

Stress was becoming a growing concern in modern societies. Its critical role in health and illness was only starting to be understood. Two San Francisco cardiologists, Meyer Friedman, MD, and Ray Rosenman, MD, first proposed the idea of a stressful Type A personality, one that was prone to heart attacks and premature death. This notion of a stress-sensitive form of personality captured the American imagination, as well as the minds of the Big Tobacco executives. They realized a windfall opportunity by linking smoking with specific personality types. All they needed was some sympathetic scientific support, and they found it, from a most credible source, Hans Selye, MD, the father of stress. If tobacco executives were seeking to engage the services of a prominent physician-scientist, there was no better person to promote the link between stress reduction and smoking than Dr. Selye.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:cigaretteHelfgottSmokingStresstobacco

Related Articles
    Lightspring / shutterstock.com

    Recent Research Probes Smoking & the Risk for Autoimmune Disease

    March 18, 2019

    It’s no secret to any health professional, including rheumatologists, that smoking cigarettes or using other tobacco-based products is unhealthy. Yet how does smoking specifically affect rheumatic diseases, and what are some of the newest findings in this area? What role do e-cigarettes have in the smoking risk landscape? Those are the sorts of questions asked…

    Drug Commercials—How Are They Still a Thing?

    July 19, 2018

    Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor. Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers,…

    Brandon Crawford / shutterstock.com

    Case Report: Blunt Smoker Denies Tobacco Use, Delaying Diagnosis

    May 12, 2022

    Cannabis arteritis mirrors thrombo­angiitis obliterans in its clinical and arteriographic presentation, but its relevant exposure is cannabis rather than tobacco.1 Whether cannabis arteritis is a subset of thromboangiitis obliterans or a unique pathologic entity is debatable. Delta-9-tetrahydrocannabinol, the primary psychoactive component of cannabis, is a peripheral vasoconstrictor.2 This offers mechanistic insight into how cannabis may…

    Passive Exposure to Smoking May Increase Rheumatoid Arthritis Risk

    November 14, 2021

    EULAR—Passive exposure to smoking during childhood or adulthood increases the risk of developing rheumatoid arthritis (RA), according to a large prospective cohort study of healthy French women presented during EULAR’s 2021 virtual European Congress of Rheumatology. Moreover, the association was mainly observed among women who had themselves never smoked.1 “In this study, we found an…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences